Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center

被引:80
作者
Freedland, SJ [1 ]
Grubb, KA [1 ]
Yiu, SK [1 ]
Humphreys, EB [1 ]
Nielsen, ME [1 ]
Mangold, LA [1 ]
Isaacs, WB [1 ]
Partin, AW [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
prostate; prostatic neoplasms; prostatectomy; prostate-specific antigen; obesity;
D O I
10.1097/01.ju.0000169459.78982.d7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We have previously reported that obesity is an independent predictor of biochemical progression after radical prostatectomy (RP) in men treated by a single surgeon at our institution. We sought to validate or refute these findings using data on men treated by multiple other surgeons at our institution. Materials and Methods: The study population consisted of 2,796 men treated with anatomical radical RP between 1988 and 2004 by 1 of 17 surgeons at our institution, a tertiary care referral center. We evaluated the association between body mass index (BMI), and adverse pathological features and biochemical progression. Results: On multivariate analysis increased BMI was associated with high grade disease in the RP specimen (p = 0.03), positive surgical margins (p. <0.001), extraprostatic extension (p <0.001) and lymph node metastasis (p = 0.01) but not with seminal vesicle invasion (p = 0.59). After multivariate adjustment for preoperative clinical characteristics increased BMI was significantly associated with an increased risk of biochemical progression (p <0.001), which was somewhat but not completely attenuated by further adjusting for RP specimen pathological features (p = 0.03). Adjustment for surgeon did not affect these results. Conclusions: In men undergoing RP increased BMI was associated with adverse pathological features and a greater risk of biochemical progression. These findings together with the results of several recently published series collectively provide strong evidence that obese men undergoing RP are more likely to have aggressive prostate cancer.
引用
收藏
页码:919 / 922
页数:4
相关论文
共 21 条
[1]   Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy [J].
Amling, CL ;
Riffenburgh, RH ;
Sun, L ;
Moul, JW ;
Lance, RS ;
Kusuda, L ;
Sexton, WJ ;
Soderdahl, DW ;
Donahue, TF ;
Foley, JP ;
Chung, AK ;
McLeod, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :439-445
[2]   The association of body mass index and prostate-specific antigen in a population-based study [J].
Baillargeon, J ;
Pollock, BH ;
Kristal, AR ;
Bradshaw, P ;
Hernandez, J ;
Basler, J ;
Higgins, B ;
Lynch, S ;
Rozanski, T ;
Troyer, D ;
Thompson, I .
CANCER, 2005, 103 (05) :1092-1095
[3]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[4]   Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy [J].
D'Amico, AV ;
Moul, JW ;
Carroll, PR ;
Sun, L ;
Lubeck, D ;
Chen, MH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1376-1383
[5]   Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies [J].
Dagnelie, PC ;
Schuurman, AG ;
Goldbohm, RA ;
Van den Brandt, PA .
BJU INTERNATIONAL, 2004, 93 (08) :1139-1150
[6]  
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
[7]  
2-Y
[8]   Obesity and prostate cancer [J].
Freedland, SJ ;
Aronson, WJ .
UROLOGY, 2005, 65 (03) :433-439
[9]   Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group [J].
Freedland, SJ ;
Aronson, WJ ;
Kane, CJ ;
Presti, JC ;
Amling, CL ;
Elashoff, D ;
Terris, MK .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :446-453
[10]   Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy [J].
Freedland, SJ ;
Sutter, ME ;
Dorey, F ;
Aronson, WJ .
UROLOGY, 2003, 61 (02) :365-369